Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yang Ding

Showing results (841-850 of 854) with videos related to

Pageof 86
Sort By:
Blood Advances|September 18, 2024
Asymptomatic multicentric Castleman disease: a potential early stage of idiopathic MCDLu Zhang, Qin-Hua Liu, Hui Zhou, et al.
Military Medical Research|March 5, 2025
Motor protein KIF13B orchestrates hepatic metabolism to prevent metabolic dysfunction-associated fatty liver diseaseGuo-Lin Miao, Wen-Xi Zhang, Yi-Tong Xu, et al.
Nature Communications|March 6, 2025
Retention of high-pressure solution-processable metastable phase to ambience via differential sublattice rigidity for broadband photodetectorsZhongyang Li, Jue Gong, Zhikai Zhu, et al.
Blood Advances|April 20, 2023
Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm studyLi-Juan Deng, Ke-Shu Zhou, Li-Hong Liu, et al.
Blood|March 16, 2025
Single-cell panleukemia signatures of HSPC-like blasts predict drug response and clinical outcomeChangya Chen, Jason Xu, Jonathan H Sussman, et al.
Leukemia & Lymphoma|June 9, 2021
Treatment and outcome patterns of patients with Waldenström's macroglobulinemia: a large, multicenter retrospective review in ChinaXin-Xin Cao, Shu-Hua Yi, Zhong-Xing Jiang, et al.
Research Square|November 14, 2023
Identification and targeting of treatment resistant progenitor populations in T-cell Acute Lymphoblastic LeukemiaKai Tan, Jason Xu, Changya Chen, et al.
Hepatology International|April 14, 2017
CSH guidelines for the diagnosis and treatment of drug-induced liver injuryYue-Cheng Yu, Yi-Min Mao, Cheng-Wei Chen, et al.
The Lancet Regional Health. Western Pacific|June 7, 2023
A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteriaLu Zhang, Yu-Jun Dong, Hong-Ling Peng, et al.
JAMA|April 22, 2026
Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: A Randomized Clinical TrialPeng-Peng Xu, Yu-Qin Song, Jian-Zhen Shen, et al.
Pageof 86

Showing results (841-850 of 854) with videos related to

Sort By:
Pageof 86
Blood Advances|September 18, 2024
Asymptomatic multicentric Castleman disease: a potential early stage of idiopathic MCDLu Zhang, Qin-Hua Liu, Hui Zhou, et al.
Military Medical Research|March 5, 2025
Motor protein KIF13B orchestrates hepatic metabolism to prevent metabolic dysfunction-associated fatty liver diseaseGuo-Lin Miao, Wen-Xi Zhang, Yi-Tong Xu, et al.
Nature Communications|March 6, 2025
Retention of high-pressure solution-processable metastable phase to ambience via differential sublattice rigidity for broadband photodetectorsZhongyang Li, Jue Gong, Zhikai Zhu, et al.
Blood Advances|April 20, 2023
Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm studyLi-Juan Deng, Ke-Shu Zhou, Li-Hong Liu, et al.
Blood|March 16, 2025
Single-cell panleukemia signatures of HSPC-like blasts predict drug response and clinical outcomeChangya Chen, Jason Xu, Jonathan H Sussman, et al.
Leukemia & Lymphoma|June 9, 2021
Treatment and outcome patterns of patients with Waldenström's macroglobulinemia: a large, multicenter retrospective review in ChinaXin-Xin Cao, Shu-Hua Yi, Zhong-Xing Jiang, et al.
Research Square|November 14, 2023
Identification and targeting of treatment resistant progenitor populations in T-cell Acute Lymphoblastic LeukemiaKai Tan, Jason Xu, Changya Chen, et al.
Hepatology International|April 14, 2017
CSH guidelines for the diagnosis and treatment of drug-induced liver injuryYue-Cheng Yu, Yi-Min Mao, Cheng-Wei Chen, et al.
The Lancet Regional Health. Western Pacific|June 7, 2023
A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteriaLu Zhang, Yu-Jun Dong, Hong-Ling Peng, et al.
JAMA|April 22, 2026
Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: A Randomized Clinical TrialPeng-Peng Xu, Yu-Qin Song, Jian-Zhen Shen, et al.
Pageof 86